Amphastar Pharmaceuticals
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise. The company is engaged in the creation, production, commerc...
Latest News
10 days ago · seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Q3 2026 Earnings Call TranscriptAmphastar Pharmaceuticals, Inc. ( AMPH ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Dan Dischner - Senior Vice President of Human Resources & Corporate Communication William Peters - CFO, Executive VP of Finance, Treasurer & Director Conference Call Participants Ekaterina Knyazkova - JPMorgan Chase & Co, Research Division Naoki Martin - Piper Sandler & Co., Research Division Yuchen Ding - Jefferies LLC, Research Division Serge Belanger - Needham & Company, LLC, Research Division Jason Gerberry - BofA Securities, Research Division Glen Santangelo - Barclays Bank PLC, Research Division Presentation Operator Greetings, and welcome to the Amphastar Pharmaceuticals Inc. Third Quarter Earnings Call. [Operator Instructions] Please note that certain statements made during this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions for future periods are forward-looking statements.
11 days ago · zacks.com
Amphastar (AMPH) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesThe headline numbers for Amphastar (AMPH) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
11 days ago · marketbeat.com
Amphastar Pharmaceuticals Q3 Earnings Call HighlightsAmphastar Pharmaceuticals NASDAQ: AMPH reported record third-quarter revenue of $207.6 million, up 8% from a year earlier, as sales of BAQSIMI and Primatene MIST and contributions from newer products offset manufacturing disruptions and lower pricing on some established medicines.
11 days ago · zacks.com
Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue EstimatesAmphastar Pharmaceuticals (AMPH) came out with quarterly earnings of $1.14 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.93 per share a year ago.
11 days ago · prnewswire.com
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call today at 2:00 p.m. Pacific Time RANCHO CUCAMONGA, Calif.
19 days ago · zacks.com
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out forAmphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
19 days ago · prnewswire.com
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026RANCHO CUCAMONGA, Calif., October 29, 2026 /PRNewswire/ -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that the Company will release results for its third quarter of 2026 ended September 30, 2026, after the market closes on Thursday, November 5, 2026, and will hold a conference call to discuss its financial results at 2:00 p.m.
1 month ago · zacks.com
Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
6 months ago · seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call TranscriptAmphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript
6 months ago · zacks.com
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key MetricsAlthough the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove AMPH